CGTX insider transaction filings
COGNITION THERAPEUTICS INC — 35 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-22. Screen CGTX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | Fletcher Aaron G.L. — Director, 10% owner BIOS Capital Management, LP — Director, 10% owner BIOS Advisors GP, LLC — Director, 10% owner Bios Equity Partners, LP — Director, 10% owner BIOS Fund I, LP — Director, 10% owner BIOS Fund II QP, LP — Director, 10% owner BIOS Memory SPV I, LP — Director, 10% owner Bios Equity Partners II, LP — Director, 10% owner BIOS Fund II, LP — Director, 10% owner BIOS Fund I QP, LP — Director, 10% owner | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-06-22 | 4 | Khattar Jack A. — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-06-22 | 4 | Monia Brett P — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-06-22 | 4 | Wallace Peggy — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-06-22 | 4 | RICHSTONE ELLEN B — Director | Grant/award (A): 25,000 @ $0 | EDGAR |
| 2026-05-04 | 4 | Doyle John Brendan — Chief Financial Officer | Tax withholding (F): 8,567 @ $1.28 | EDGAR |
| 2026-04-20 | 4 | Doyle John Brendan — Chief Financial Officer | Purchase (P): 10,000 @ $1.13 | EDGAR |
| 2026-04-20 | 4 | Caggiano Anthony — Chief Medical Officer | Purchase (P): 10,000 @ $1.11 | EDGAR |
| 2026-04-20 | 4 | Ricciardi Lisa — CEO & President, Director | Purchase (P): 9,175 @ $1.10 | EDGAR |
| 2026-02-18 | 4 | Doyle John Brendan — Chief Financial Officer | Tax withholding (F): 1,560 @ $1.12 | EDGAR |
| 2026-02-18 | 4 | Caggiano Anthony — Chief Medical Officer | Tax withholding (F): 4,680 @ $1.12 | EDGAR |
| 2026-02-18 | 4 | Ricciardi Lisa — CEO & President, Director | Tax withholding (F): 5,850 @ $1.12 | EDGAR |
| 2026-02-05 | 4 | Doyle John Brendan — Chief Financial Officer | Grant/award (A): 200,000 @ $0 · Tax withholding (F): 26,921 @ $1.03 | EDGAR |
| 2026-02-05 | 4 | Caggiano Anthony — Chief Medical Officer | Grant/award (A): 400,000 @ $0 · Tax withholding (F): 11,488 @ $1.12 · Tax withholding (F): 26,919 @ $1.03 | EDGAR |
| 2026-02-05 | 4 | Ricciardi Lisa — CEO & President, Director | Grant/award (A): 800,000 @ $0 · Tax withholding (F): 26,036 @ $1.12 · Tax withholding (F): 51,704 @ $1.03 | EDGAR |
| 2025-12-22 | 4 | Caggiano Anthony — Chief Medical Officer | Grant/award (A): 65,000 @ $0 · Tax withholding (F): 20,280 @ $1.50 | EDGAR |
| 2025-12-22 | 4 | Doyle John Brendan — Chief Financial Officer | Grant/award (A): 30,000 @ $0 · Tax withholding (F): 9,360 @ $1.50 | EDGAR |
| 2025-12-22 | 4 | Ricciardi Lisa — CEO & President, Director | Grant/award (A): 75,000 @ $0 · Tax withholding (F): 23,400 @ $1.50 | EDGAR |
| 2025-09-23 | 4 | Fletcher Aaron G.L. — Director, 10% owner | Option exercise (M): 7,729 @ $0.84 · Option exercise (M): 7,729 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Caggiano Anthony — Chief Medical Officer | Grant/award (A): 65,000 @ $0 · Tax withholding (F): 20,281 @ $0.67 | EDGAR |
| 2025-07-31 | 4 | Doyle John Brendan — Chief Financial Officer | Grant/award (A): 30,000 @ $0 · Tax withholding (F): 9,360 @ $0.67 | EDGAR |
| 2025-07-31 | 4 | Ricciardi Lisa — CEO & President, Director | Grant/award (A): 75,000 @ $0 · Tax withholding (F): 23,400 @ $0.67 | EDGAR |
| 2025-06-23 | 4 | Khattar Jack A. — Director | Grant/award (A): 34,000 @ $0 | EDGAR |
| 2025-06-23 | 4 | Wallace Peggy — Director | Grant/award (A): 34,000 @ $0 | EDGAR |
| 2025-06-23 | 4 | Monia Brett P — Director | Grant/award (A): 34,000 @ $0 | EDGAR |
| 2025-06-23 | 4 | RICHSTONE ELLEN B — Director | Grant/award (A): 34,000 @ $0 | EDGAR |
| 2025-06-20 | 4 | Kreis Leslie W. — Director, 10% owner Cavu Advisors, LLC — Director, 10% owner Cavu Management, LP — Director, 10% owner BIOS Fund II NT, LP — Director, 10% owner BIOS Memory SPV II, LP — Director, 10% owner BIOS Equity Partners III, LP — Director, 10% owner BIOS Fund III, LP — Director, 10% owner BIOS Fund III QP, LP — Director, 10% owner BIOS Fund III NT, LP — Director, 10% owner BP Directors, LP — Director, 10% owner | Grant/award (A): 34,000 @ $0 | EDGAR |
| 2025-06-20 | 4 | Fletcher Aaron G.L. — Director, 10% owner BIOS Capital Management, LP — Director, 10% owner BIOS Advisors GP, LLC — Director, 10% owner Bios Equity Partners, LP — Director, 10% owner BIOS Fund I, LP — Director, 10% owner BIOS Fund I QP, LP — Director, 10% owner BIOS Memory SPV I, LP — Director, 10% owner Bios Equity Partners II, LP — Director, 10% owner BIOS Fund II, LP — Director, 10% owner BIOS Fund II QP, LP — Director, 10% owner | Grant/award (A): 34,000 @ $0 | EDGAR |
| 2025-05-02 | 4 | Doyle John Brendan — Chief Financial Officer | Tax withholding (F): 9,692 @ $0.45 | EDGAR |
| 2025-02-18 | 4 | Caggiano Anthony — Chief Medical Officer | Tax withholding (F): 5,296 @ $0.59 | EDGAR |
| 2025-02-18 | 4 | Doyle John Brendan — Chief Financial Officer | Tax withholding (F): 1,723 @ $0.59 | EDGAR |
| 2025-02-18 | 4 | Ricciardi Lisa — CEO & President, Director | Tax withholding (F): 6,619 @ $0.59 | EDGAR |
| 2025-02-04 | 4 | Caggiano Anthony — Chief Medical Officer | Tax withholding (F): 12,779 @ $0.67 · Grant/award (A): 295,000 @ $0 | EDGAR |
| 2025-02-04 | 4 | Doyle John Brendan — Chief Financial Officer | Grant/award (A): 295,000 @ $0 | EDGAR |
| 2025-02-04 | 4 | Ricciardi Lisa — CEO & President, Director | Purchase (P): 38,851 @ $0.77 · Tax withholding (F): 28,960 @ $0.67 · Grant/award (A): 631,300 @ $0 | EDGAR |
Recent 8-K events — COGNITION THERAPEUTICS INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-27 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CGTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →